Skip to content

Penumbra PEN Price / book

Price / book at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
7.3×+2.1×
Medtronic logo
MedtronicMDT
2.1×-0.1×
Boston Scientific logo
Boston ScientificBSX
3.6×-3.1×

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Calculated from Penumbra’s reported figures.

Based on the most recent quarter.

The official record: Penumbra’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Penumbra's price / book?
Penumbra (PEN) reported price / book of 8.7× in Q1 2026.
How has Penumbra's price / book changed year-over-year?
Penumbra's price / book increased by 3.0% year-over-year, from 8.5× to 8.7×.
What is the long-term trend for Penumbra's price / book?
Over 5 years (2020 to 2025), Penumbra's price / book has grown at a -3.5% compound annual growth rate (CAGR), from 10.2× to 8.5×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.